- Home
- Articles
- latamerica
- tumor response
Tumor Response Articles & Analysis
31 articles found
The large T antigen of SV40 has the capability to bind and inactivate tumor suppressor proteins such as p53 and Rb, which are critical regulators of the cell cycle. ...
Cancer Treatment: By delivering genes that can induce cancer cell death or enhance the immune response against tumors, adenoviruses are part of innovative approaches in oncology. ...
Through this project, the POAI active machine learning technology constructed a predictive model of tumor sample response to NPDC’s targeted drugs in a highly efficient manner, saving approximately 18 months of wet lab work in the process. Several NPDC compounds demonstrated efficacy across multiple tumor types and are now well positioned ...
Circulating Tumor Cells, or CTCs, are cancer cells that have shed from the primary tumor and enter the bloodstream, where they can travel and potentially lead to metastasis. ...
These conventional models frequently provided misleading results, leading to high failure rates in clinical trials. In response, researchers have developed comprehensive disease models that incorporate multiple biological components, enabling a more holistic understanding of disease mechanisms and therapeutic responses. ...
Alfa Cytology’s Ovarian Cancer Therapy Development Services aim to bridge this gap by offering highly customized, robust therapeutic solutions that correspond with ovarian tumors’ unique biological and molecular characteristics. These services include developing targeted therapies, immunotherapy, and inhibitors and drugs. ...
They play critical roles in regulating inflammation, tumor growth, and immune responses. In mouse models, quantifying these molecules provides valuable insights into both physiological and pathological processes. For example, in cancer research, cytokine analysis helps identify tumor biomarkers, validate cancer-related genes, and evaluate the ...
Researchers use these models because they retain many of the biological properties of the original tumors, thus providing insights into the cancer’s behavior. The establishment of cell lines involves extracting cancer cells from a tumor biopsy, followed by their growth in a nutrient-rich medium under sterile conditions. ...
In eukaryotic cells, RNA polymerase II is specifically responsible for synthesizing mRNA. Its accuracy and efficiency are crucial to maintaining correct genetic coding. ...
Alfa Cytology has introduced its advanced drug development services for brain tumors. Alfa Cytology, celebrated for its cutting-edge biotech solutions and extensive tumor research expertise, has recently introduced brain tumor drug development services, designed to empower researchers in understanding the intricacies and unique challenges ...
Even different tumor cells within the same tumor differ in their metabolic patterns. ...
Brain tumors can be broadly categorized into primary and secondary (or metastatic) tumors. ...
Therefore, it can be well modified on its surface, such as coating with cell membrane, for the design and development of tumor vaccines. CpG is a type of oligodeoxynucleotide that can be used as an immune adjuvant to stimulate the maturation and development of antigen-presenting cells. CpG can be encapsulated with PLGA using the emulsion evaporation method. The ...
However, traditional liposomes still have shortcomings such as unsatisfactory targeting distribution characteristics and poor stability, which limit their application in tumor chemotherapy. pH-responsive liposomes pH-sensitive liposomes are destroyed in the acidic environment of the tumor, thereby tending to release antineoplastic drugs to the ...
NIR-PIT drugs can form a new targeted anti-tumor platform that irradiates infrared light to the tumor site through the device. ...
It is a new type of precision targeted therapy for the treatment of tumors. Compared with traditional chemotherapy and hematopoietic stem cell transplantation, it is more precise in killing tumor cells and significantly reduces toxic side effects while improving efficacy. ...
Notably, both cancer cells and host cells employ inducible CD73 expression, alongside other adenosinergic molecules, to establish and perpetuate an immunosuppressive microenvironment within the tumor. This orchestrated strategy affects various dimensions of the immune response. ...
CADM molecules, particularly CADM1, have been implicated in tumor immune escape due to their involvement in immune cell interactions and regulation of immune responses. ...
High internalization is not necessarily beneficial to the treatment of solid tumors, because the rapid degradation of ADCs limits their ability to penetrate tumor masses. ...
Currently, ADC has played a significant role in the treatment of some malignant tumors, such as trastuzumab in the treatment of breast cancer, but its application in the treatment of prostate cancer (PCa) progress slowly. ...